- TLDR; On this page you will find a compiled list of key urls, charts and videos or podcasts about norwegian healthcare stocks! It is my hope it will be a useful gateway (drug) for investors new to this list.
Please note that this post was written at december 29th of 2020, and some facts may have changed since then, but the main themes should remain relevant for a long time.
Vaccibody
Medistim
ArcticZymes
Photocure
Ultimovacs
BergenBio
Nordic Nanovector
PCI Biotech
Targovax
Soft·Ox
Natto Pharma
Navamedic - The Oslo stock exchange has traditionally been extremely focused on Oil, Shipping, Fish and Industry, with healthcare stocks being an unpopular, undercovered and underpriced backwater, compared with other norwegian stocks, and especially with peer companies listed in Europe and the US.
- This is starting to change with a concerted effort in the previous decade, with the Bayer acquisition of Algeta being the main success story, and a brief rally during 2016-2017 leading up to a three year bear market that ended in the fall of 2019.
Key factor to this is in short: Maturing pipelines. - Key parts of this are the Oslo Cancer Clusterđź”— and institutional early phase investors such as Radforskđź”— and Inven2đź”—
- To help new investors get a quick glimpse into the sector I have compiled this list that will hopefully be of use. It is sorted descendingly by market cap as of december 28th 2020, with some updates added in early january 2021.
Norwegian Healthcare Index in a strong and sustained uptrend after a three-year bear market ended late 2019
- Note that Vaccibody is listed on Euronext Growth market and as such is not included in the Oslo Stock Exchange Indices
Vaccibody $VACC – The shining star of Norwegian Biotech 2020
- Market cap: 21,3 billion NOK (Note that extra digit!)
- IR: https://www.vaccibody.com/financial-reports-and-presentations/
- Euronext: https://live.euronext.com/nb/product/equities/NO0010714785-MERK
- In october 2020, right before its listing on the Euronext Growth Market, Vaccibody announced the largest biotech deal in Norway ever signed, when it licensed one part of its platform to Genentech in a 700 million USD deal.
https://occincubator.com/largest-biotech-agreement-ever-made-in-norway/
Medistim $MEDI – The high quality medtech powertrain
- Market cap: 4,4 billion NOK
- A dividend paying stock!
- Twitter: https://twitter.com/Medistim
- IR: https://medistim.com/investor-relations/
- Euronext: https://live.euronext.com/nb/product/equities/NO0010159684-XOSL
- Medistim has been a very successfully growth stock within the heart surgery medtech field for over a decade.
Arcticzymes $AZT – The stock market comeback of a decade
- Market cap: 2,9 billion NOK
- Twitter: https://twitter.com/arcticzymes
- IR: https://arcticzymes.com/investors/
- Euronext: https://live.euronext.com/nb/product/equities/NO0010014632-XOSL
- This year, Biotec Pharmacon divested assets that were not performing strongly in the market, and rebranded to focus fully on its Cod Enzyme branch.
Legendary timing as this is a key ingredient for Pharma companies working with Covid 19.
BerGenBio $BGBIO- The AXL oncology company that had a Covid19 trick up its sleeve
- Market cap: 2,8 billion NOK
- Twitter: https://twitter.com/BGenBio
- IR: https://www.bergenbio.com/investors/
- Euronext: https://live.euronext.com/nb/product/equities/NO0010650013-XOSL
- BergenBio is a company based in Oxford, England and Bergen, Norway, and has been focused on AXL as a vector for treating cancers.
The company shocked the market when it announced in march that UK would also be trialling its lead product Bemcentinib in its Covid 19 trials. - The company has seized on this opportunity by doing equity offerings that has secured its financial runway for a long time into the future.
Photocure $PHO – The Bladder Cancer (Blue light) Company
- Market cap: 2,7 billion NOK
- Twitter: https://twitter.com/PhotocureASA
- IR: https://photocure.com/investor/why-invest/
- Euronext: https://live.euronext.com/nb/product/equities/NO0010000045-XOSL
Ultimovacs $ULTI – The universal cancer vaccine wonderchild
- Market cap: 2,7 billion NOK
- Twitter: https://twitter.com/ultimovacs
- IR: https://ultimovacs.com/investors
- Euronext: https://live.euronext.com/nb/product/equities/NO0010851603-XOSL
- Four ongoing phase 2 studies
Nordic Nanovector $NANOV – The second radioimmunotherapy brainchild from Algeta founders Larsen & Bruland
- Market cap: 1,3 billion NOK
- IR: https://www.nordicnanovector.com/investors-and-media/investor-relations
- Euronext: https://live.euronext.com/nb/product/equities/NO0010597883-XOSL
- See also my compilation webpage with huge amounts of NANOV and Betalutin info:
https://nanoinvestors.wordpress.com/
PCI Biotech $PCIB – Drug Delivery Platform company using photochemical internalization
- Market cap: 1,05 billion NOK
- IR: https://www.pcibiotech.no/reportsandpresentations
- Euronext: https://live.euronext.com/nb/product/equities/NO0010405640-XOSL
Targovax $TRVX – The worlds cheapest oncolytic virus?
- Market cap: 880 million NOK
- Twitter: https://twitter.com/targovax
- IR: https://www.targovax.com/en/
- Euronext: https://live.euronext.com/nb/product/equities/NO0010689326-XOSL
- The companys main focus is its ONCOS-102 Oncolytic Virus, which it recently reported encouraging data from in two separate clinical trials.
Presentation: https://www.targovax.com/en/wp-content/uploads/sites/2/2019/03/2012-trvx-trial-updates-2.pdf
Webcast: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20201202_5
Softox $SOFTX – Fighting infections with its exciting hypochloric acid platform
- Market cap: 540 million NOK
- Twitter: https://twitter.com/SoftOxSolutions
- IR: https://soft-ox.com/investor-relations/
- Euronext: https://live.euronext.com/nb/product/equities/NO0010811961-MERK
- The University of Copenhagen recently explained it finds the preclinical minipig studies of the Softox Inhalation product as a potential game changing invention in fighting airways infections such as Covid 19
Read more: https://healthsciences.ku.dk/newsfaculty-news/2020/12/danish-researchers-inhalation-treatment-for-covid-19-passes-animal-testing/
NattoPharma $NATTO – K2 Vitamin growth machine
- Market cap: 408 million NOK (per january 4th 2021)
- Twitter: https://twitter.com/SoftOxSolutions
- IR: https://www.nattopharma.com/investors-relations/
- Euronext: https://live.euronext.com/en/product/equities/NO0010289200-XOSL
- Note attempted hostile takeover ongoing per january 2021!
Navamedic $NAVA – Nordic-based pharmaceutical company
- Market cap: 297 million NOK (per january 4th 2021)
- IR: https://navamedic.com/investors/
- Euronext: https://live.euronext.com/nb/product/equities/NO0010205966-XOSL